CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.
CHAIN Biotechnology has raised $2.3M in total funding. The most recent round was Seed. The last funding was announced in July 2023.
CHAIN Biotechnology's investors include Business Growth Fund, Innovate UK, Future Planet Capital, UK Innovation & Science Seed Fund, SynBioVen.
CHAIN Biotechnology is headquartered in Marlow, United Kingdom.
CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.
CHAIN Biotechnology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CHAIN Biotechnology — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/chain-biotechnology. Accessed August 2, 2026.
VCBacked. (2023). CHAIN Biotechnology — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/chain-biotechnology
{{cite web |title=CHAIN Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/chain-biotechnology |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated